Eli Lilly established a dedicated laboratory facility outside Stanford University in Silicon Valley to collaborate directly with Nvidia on artificial intelligence

Artificial intelligence applications across healthcare, covering clinical decision support, diagnostics, workflow automation, drug discovery, patient monitoring, safety risks, equity concerns, and regulation.